Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma

Published:2024-07-10 Issue:8 Volume:44 Page:921-925
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Hyun Sangyeop¹,Han Youngmin²,Moon Jae Yun³,Suh Young‐Ah²,Yun Won‐Gun²,Kwon Wooil²,Lee Jong‐Eun⁴,Kim Daeun¹,Ku Ja‐Lok⁵,Jang Jin‐Young²,Park Daechan¹^ORCID

Affiliation:

1. Department of Molecular Science and Technology Ajou University Suwon Republic of Korea

2. Department of Surgery and Cancer Research Institute Seoul National University College of Medicine Seoul Republic of Korea

3. Molecular Science and Technology Research Center Ajou University Suwon Republic of Korea

4. DNA Link Inc. Seoul Republic of Korea

5. Korean Cell Line Bank, Laboratory of Cell Biology Cancer Research Institute, Seoul National University College of Medicine Seoul Republic of Korea

Funder

National Research Foundation of Korea

Kementerian Pendidikan

Ministry of Science and ICT, South Korea

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12585

Reference10 articles.

1. Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

2. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance

3. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

4. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

5. Genomic analyses identify molecular subtypes of pancreatic cancer